These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17881618)

  • 1. Effects of estrogens and selective estrogen receptor modulators on vascular reactivity in the perfused mesenteric vascular bed.
    Mark CJ; Tatchum-Talom R; Martin DS; Eyster KM
    Am J Physiol Regul Integr Comp Physiol; 2007 Nov; 293(5):R1969-75. PubMed ID: 17881618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute vascular effects of the selective estrogen receptor modulator EM-652 (SCH 57068) in the rat mesenteric vascular bed.
    Tatchum-Talom R; Martel C; Labrie F; Marette A
    Cardiovasc Res; 2003 Feb; 57(2):535-43. PubMed ID: 12566126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressions of vascular endothelial growth factor and nitric oxide synthase III in the thyroid gland of ovariectomized rats are upregulated by estrogen and selective estrogen receptor modulators.
    de Araujo LF; Grozovsky R; dos Santos Pereira MJ; de Carvalho JJ; Vaisman M; Carvalho DP
    Thyroid; 2010 Jan; 20(1):85-92. PubMed ID: 20017619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Direct Vascular Actions of Estrogens.
    Martin DS; Eyster KM
    Methods Mol Biol; 2016; 1366():533-548. PubMed ID: 26585162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens and selective estrogen receptor modulators regulate gene and protein expression in the mesenteric arteries.
    Mark-Kappeler CJ; Martin DS; Eyster KM
    Vascul Pharmacol; 2011; 55(1-3):42-9. PubMed ID: 21658471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of alone and combination tamoxifen, raloxifene and estrogen on lipid profile and atherogenic index of ovariectomized type 2 diabetic rats.
    Ebrahimi MN; Khaksari M; Sepehri G; Karam GA; Raji-Amirhasani A; Azizian H
    Life Sci; 2020 Dec; 263():118573. PubMed ID: 33058909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats.
    Lamas AZ; Nascimento AM; Medeiros ARS; Caliman IF; Dalpiaz PLM; Firmes LB; Sousa GJ; Oliveira PWC; Andrade TU; Reis AM; Gouvea SA; Bissoli NS
    Pharmacol Rep; 2017 Aug; 69(4):798-805. PubMed ID: 28591668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.
    Landry M; Di Paolo T
    Brain Res Mol Brain Res; 2003 Apr; 112(1-2):82-9. PubMed ID: 12670705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine.
    Zoma WD; Baker RS; Kopernik G; Mershon JL; Clark KE
    Am J Obstet Gynecol; 2002 Dec; 187(6):1555-60. PubMed ID: 12501063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulators prevent neointima formation after vascular injury.
    Savolainen-Peltonen H; Luoto NM; Kangas L; Häyry P
    Mol Cell Endocrinol; 2004 Nov; 227(1-2):9-20. PubMed ID: 15501580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
    Gogos A; van den Buuse M
    Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in vascular reactivity of mesenteric arterioles in portal hypertensive and non-portal hypertensive rats.
    Zhang B; Ji LH; Zhang CG; Zhao G; Wu ZY
    World J Gastroenterol; 2019 Oct; 25(39):5953-5960. PubMed ID: 31660032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different sensitivities of vasoconstrictor responses to serotonin and KCl of isolated and perfused dog mesenteric arteries with and without endothelia.
    Chiba S; Tsukada M
    Jpn J Pharmacol; 1985 Oct; 39(2):271-3. PubMed ID: 4087571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 released by vascular smooth muscle cells enhances vascular responsiveness of rat mesenteric arterial bed exposed to high perfusion flow.
    Russo D; Minutolo R; Clienti C; De Nicola L; Iodice C; Savino FA; Andreucci VE
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1119-23. PubMed ID: 10604489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supersensitivity to serotonin- and histamine-induced arterial contraction following ovariectomy.
    Ma L; Yu Z; Xiao S; Thadani U; Robinson CP; Patterson E
    Eur J Pharmacol; 1998 Oct; 359(2-3):191-200. PubMed ID: 9832391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus.
    Helvering LM; Adrian MD; Geiser AG; Estrem ST; Wei T; Huang S; Chen P; Dow ER; Calley JN; Dodge JA; Grese TA; Jones SA; Halladay DL; Miles RR; Onyia JE; Ma YL; Sato M; Bryant HU
    Biol Reprod; 2005 Apr; 72(4):830-41. PubMed ID: 15576828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutically relevant concentrations of raloxifene dilate pressurized rat resistance arteries via calcium-dependent endothelial nitric oxide synthase activation.
    Chan YC; Leung FP; Wong WT; Tian XY; Yung LM; Lau CW; Tsang SY; Yao X; Chen ZY; Huang Y
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):992-9. PubMed ID: 20185791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.